Bio-Rad Laboratories
BIO
#2669
Rank
NZ$11.23 B
Marketcap
NZ$419.99
Share price
1.13%
Change (1 day)
4.06%
Change (1 year)
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.

Revenue for Bio-Rad Laboratories (BIO)

Revenue in 2026 (TTM): NZ$4.42 Billion

According to Bio-Rad Laboratories's latest financial reports the company's current revenue (TTM ) is NZ$4.41 Billion. In 2025 the company made a revenue of NZ$4.46 Billion a decrease over the revenue in the year 2024 that were of NZ$4.55 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Rad Laboratories from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) NZ$4.42 B-0.87%
2025 NZ$4.46 B-1.99%
2024 NZ$4.55 B7.73%
2023 NZ$4.22 B-4.3%
2022 NZ$4.41 B3.15%
2021 NZ$4.27 B21.28%
2020 NZ$3.52 B2.79%
2019 NZ$3.43 B0.57%
2018 NZ$3.41 B12.26%
2017 NZ$3.04 B1.83%
2016 NZ$2.98 B1.19%
2015 NZ$2.95 B6.29%
2014 NZ$2.77 B6.96%
2013 NZ$2.59 B3.18%
2012 NZ$2.51 B-5.32%
2011 NZ$2.65 B6.36%
2010 NZ$2.49 B1.68%
2009 NZ$2.45 B-19.2%
2008 NZ$3.04 B59.4%
2007 NZ$1.90 B5.48%
2006 NZ$1.80 B4.65%
2005 NZ$1.72 B13.11%
2004 NZ$1.52 B-0.03%
2003 NZ$1.52 B-10.42%
2002 NZ$1.70 B-13.36%
2001 NZ$1.96 B19.34%
2000 NZ$1.64 B56.92%
1999 NZ$1.05 B25.38%
1998 NZ$0.83 B13.96%
1997 NZ$0.73 B24.1%
1996 NZ$0.59 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
NZ$164.33 B 3,620.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$77.07 B 1,645.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
NZ$12.04 B 172.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$37.38 B 746.52%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$82.39 B 1,765.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$42.25 B 856.72%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
NZ$5.72 B 29.64%๐Ÿ‡บ๐Ÿ‡ธ USA